# Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent Manner

> **NCT03415503** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 169 (actual)

## Conditions studied

- Dyslipidemias

## Interventions

- **DRUG:** Medox® Anthocyanin capsules

## Key facts

- **NCT ID:** NCT03415503
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-10-01
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2020-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03415503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03415503, "Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent Manner". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03415503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*